Hawley Seeks Answers About Data Used in FDA Abortion Drug Study
October 09, 2026
October 09, 2026
WASHINGTON, Oct. 9 -- Sen. Josh Hawley, R-Missouri, issued the following news release:
* * *
Hawley Seeks Answers About Data Used in FDA Abortion Drug Study
*
WASHINGTON -- Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Acting Commissioner Kyle Diamantas raising concerns that the FDA's long-promised safety study of the abortion drug mifepristone may be using incomplete data. The letter raises qu . . .
* * *
Hawley Seeks Answers About Data Used in FDA Abortion Drug Study
*
WASHINGTON -- Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Acting Commissioner Kyle Diamantas raising concerns that the FDA's long-promised safety study of the abortion drug mifepristone may be using incomplete data. The letter raises qu . . .